罗萨伊-多尔夫曼病的眼科表现
该回顾性病例系列描述了1992至2016年梅奥诊所76例罗萨伊-多尔夫曼病(RDD)患者中8例有眼科表现者的眼部、病理及BRAF V600E突变状态,发现眼部受累者均为多器官病变,而眶内肿块者全身病变较局限,有眼科表现者倾向更年轻且视力更差,所有可检测标本BRAF突变均阴性。
要点
- 76例RDD中15例接受眼科检查,8例有眼科表现,其中4例眼部受累、4例眶内肿块。
- 眼部受累者均有多器官病变(气管、主动脉、肾、骨骼及软组织),眶内肿块者全身病变较局限。
- 有眼科表现者较无眼科表现者倾向更年轻(中位42岁 vs 56岁)且视力更差(中位logMAR 0.048 vs 0.000),差异均未达统计学显著。
核心结论
- 在本系列有眼科表现的RDD患者中,眼部受累者有多器官病变,而眶内肿块者全身病变较局限。
- 有眼科表现的患者倾向更年轻且视力更差。
- 眼科RDD似乎与BRAF突变无关。
研究设计与样本
- 回顾性病例系列,回顾1992至2016年梅奥诊所所有RDD病例,识别有眼科表现者(n=8)。
- 对组织可用的病例进行BRAF免疫染色和BRAF V600E突变分子研究。
主要发现
- 76例RDD患者中15例接受眼科检查,其中8例(5女3男)有眼科表现。
- 有眼科表现与无眼科表现的RDD患者相比,中位(范围)年龄分别为42(15-70)岁和56(32-79)岁(P=0.13)。
- 有眼科表现与无眼科表现的RDD患者相比,中位(范围)logMAR视力分别为0.048(0.000-1.824)和0.000(-0.124至0.301)(P=0.19)。
- 8例有眼科表现者中,4例眼部受累,4例眶内肿块;眼部受累者均有多器官疾病(n=4),眶内肿块者无全身受累(n=2)、仅骨骼受累(n=1)或多器官疾病(n=1)。
- 所有可检测标本(n=6)BRAF免疫染色和分子研究均阴性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the ophthalmic, pathologic, and BRAF V600E mutation status of Rosai-Dorfman disease (RDD). DESIGN: Retrospective case series. METHODS: A retrospective review of all cases of RDD seen at Mayo Clinic from 1992 to 2016 identified patients with ophthalmic manifestations (n = 8). Immunostain for BRAF and molecular studies for BRAF V600E mutation were performed on cases with tissue available. RESULTS: Of 76 patients with RDD, 15 had eye examinations; of those, 8 (5 female and 3 male) had ophthalmic manifestations. In RDD patients with ophthalmic manifestations compared to RDD patients without ophthalmic manifestations, the respective median (range) age in years was 42 (15-70) and 56 (32-79) (P = .13) and median (range) logMAR visual acuity was 0.048 (0.000-1.824) and 0.000 (-0.124 to 0.301) (P = .19). Of the 8 patients with ophthalmic manifestations, 4 had ocular involvement and 4 had orbital masses. Patients with ocular involvement had multiorgan disease including tracheal, aortic, renal, skeletal, and soft tissue lesions (n = 4). Patients with orbital masses had no systemic involvement (n = 2), skeletal involvement only (n = 1), or multiorgan disease (n = 1). BRAF immunostaining and molecular studies were negative in all available specimens (n = 6). CONCLUSIONS: In this series of patients with ophthalmic manifestations of RDD, those with ocular involvement had multiorgan disease while those with orbital masses had more limited systemic disease. Patients with ophthalmic manifestations tended to be younger and have worse visual acuity. Additionally, ophthalmic RDD does not seem to be associated with BRAF mutation.
引用
- Choi MB, Salomão DR, Smith WM, et al. Ophthalmic Findings of Rosai-Dorfman Disease. Am J Ophthalmol. 2018. PMID: 29428455. doi:10.1016/j.ajo.2018.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。